Skip to content

Clinical trials

Carcinoma, Merkel Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Merkel Cell Country / region: United States Clear all

110 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20091
20102
20121
20131
20144
20155
20165
20179
20188
201915
20209
202111
20226
202310
20244
20257
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Terminated26
Recruiting24
Active, not recruiting17
Unknown status3
Not yet recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)9
Memorial Sloan Kettering Cancer Center5
Fate Therapeutics4
H. Lee Moffitt Cancer Center and Research Institute4
Incyte Biosciences International Sàrl4
Incyte Corporation4
Fred Hutchinson Cancer Center3
ImmunityBio, Inc.3
M.D. Anderson Cancer Center3
Mayo Clinic3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Merkel Cell110
Melanoma50
Carcinoma, Non-Small-Cell Lung32
Carcinoma, Renal Cell31
Stomach Neoplasms27
Uterine Cervical Neoplasms27
Small Cell Lung Carcinoma26
Carcinoma, Hepatocellular22
Carcinoma, Transitional Cell21
Squamous Cell Carcinoma of Head and Neck21

Trials

Showing 1 to 25 of 110. Each trial links to its page on Pharma Observatory.

10 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.